Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004334115 | SCV005004662 | uncertain significance | Inborn genetic diseases | 2024-03-01 | criteria provided, single submitter | clinical testing | The c.2279G>T (p.G760V) alteration is located in exon 11 (coding exon 11) of the PKD1 gene. This alteration results from a G to T substitution at nucleotide position 2279, causing the glycine (G) at amino acid position 760 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV003332927 | SCV005643135 | uncertain significance | Polycystic kidney disease, adult type | 2024-04-18 | criteria provided, single submitter | clinical testing | |
Immunogenetics and Transplant Biology Service, |
RCV003332927 | SCV004040467 | likely benign | Polycystic kidney disease, adult type | 2023-07-03 | no assertion criteria provided | clinical testing |